TipRanks
Go Ultimate55% OFF

Compare Luye Pharma Group (LUP) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:LUPLuye Pharma GroupEUR 0.18EUR 710.95M7.73-46.06%NeutralUnlock the DE:LUP analyst price target with TipRanks PremiumDE:LUPUnlock the DE:LUP top-analyst price target with TipRanks Premium
HK:1093CSPC Pharmaceutical GroupHKD 7.87HKD 90.26B10.255.29%Strong BuyUnlock the HK:1093 analyst price target with TipRanks PremiumDE:LUP vs HK:1093Unlock the HK:1093 top-analyst price target with TipRanks Premium
HK:9688Zai Lab LtdHKD 17.37HKD 21.69B-12.70-14.77%Strong BuyUnlock the HK:9688 analyst price target with TipRanks PremiumDE:LUP vs HK:9688Unlock the HK:9688 top-analyst price target with TipRanks Premium
HK:1681Consun Pharmaceutical Group Ltd.HKD 15.25HKD 12.54B9.361.33%Moderate BuyUnlock the HK:1681 analyst price target with TipRanks PremiumDE:LUP vs HK:1681Unlock the HK:1681 top-analyst price target with TipRanks Premium
HK:2157Lepu Biopharma Co. Ltd. Class HHKD 3.16HKD 5.69B19.79-50.70%Moderate BuyUnlock the HK:2157 analyst price target with TipRanks PremiumDE:LUP vs HK:2157Unlock the HK:2157 top-analyst price target with TipRanks Premium
HK:2616CStone PharmaceuticalsHKD 4.94HKD 7.77B-15.49-20.45%Moderate BuyUnlock the HK:2616 analyst price target with TipRanks PremiumDE:LUP vs HK:2616Unlock the HK:2616 top-analyst price target with TipRanks Premium

Performance Comparison

-75%-50%-25%0%25%50%75%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:LUPLuye Pharma Group0.18-0.18-49.72%
HK:1093CSPC Pharmaceutical Group7.870.506.75%
HK:9688Zai Lab Ltd17.37-3.65-17.36%
HK:1681Consun Pharmaceutical Group Ltd.15.251.007.00%
HK:2157Lepu Biopharma Co. Ltd. Class H3.15-3.23-50.55%
HK:2616CStone Pharmaceuticals4.94-1.28-20.58%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts